Parkinson's Foundation PD GENEration Genetic Registry
Sponsored by Parkinson's Foundation
About this study
Development of a central repository for PD-related genomic data for future research.
The purpose of this study is to develop a central repository for PD-related genomic data by individuals who consent to deposit their data and bank their residual DNA obtained through clinical genetic testing for future research use.
Where this study is enrolling (50)
- I'm interested
Barrow Neurological Institute
Phoenix, Arizona
- I'm interested
University of Arkansas
Fayetteville, Arkansas
- I'm interested
University of California San Diego (UCSD)
La Jolla, California
- I'm interested
University of California San Francisco (UCSF)
San Francisco, California
- I'm interested
University of Southern California
Los Angeles, California
Show all 50 locations
- I'm interested
University of California Los Angeles
Los Angeles, California
- I'm interested
Stanford University
Redwood City, California
- I'm interested
University of Colorado Anschutz
Aurora, Colorado
- I'm interested
University of Connecticut
Farmington, Connecticut
- I'm interested
University of Miami
Miami, Florida
- I'm interested
University of Florida
Gainesville, Florida
- I'm interested
Parkinson's Disease & Movement Disorder Center of Boca Raton
Boca Raton, Florida
- I'm interested
Morehouse College
Atlanta, Georgia
- I'm interested
The Queen's Health System
Honolulu, Hawaii
- I'm interested
Northwestern University
Evanston, Illinois
- I'm interested
Rush University
Chicago, Illinois
- I'm interested
University of Chicago
Chicago, Illinois
- I'm interested
University of Illinois-Chicago
Chicago, Illinois
- I'm interested
University of Iowa
Iowa City, Iowa
- I'm interested
University of Kansas
Lawrence, Kansas
- I'm interested
University of Kentucky
Lexington, Kentucky
- I'm interested
Louisiana State University
Shreveport, Louisiana
- I'm interested
Johns Hopkins
Baltimore, Maryland
- I'm interested
University of Maryland
College Park, Maryland
- I'm interested
Massachusetts General Hospital (MGH)
Boston, Massachusetts
- I'm interested
Beth Israel Deaconess Medical Center (BIDMC)
Boston, Massachusetts
- I'm interested
Struthers Parkinson's Center - HealthPartners Park Nicollet
Golden Valley, Minnesota
- I'm interested
Cleveland Clinic Lou Ruvo Center for Brain Health
Las Vegas, Nevada
- I'm interested
University of New Mexico
Albuquerque, New Mexico
- I'm interested
University of Rochester Medical Center
Rochester, New York
- I'm interested
Columbia University
New York, New York
- I'm interested
Mount Sinai
New York, New York
- I'm interested
University of North Carolina - Chapel Hill
Chapel Hill, North Carolina
- I'm interested
Ohio State University
Colombus, Ohio
- I'm interested
Case Western Reserve University
Cleveland, Ohio
- I'm interested
Cleveland Clinic
Cleveland, Ohio
- I'm interested
Oregon Health and Science University
Portland, Oregon
- I'm interested
Allegheny Health Network
Pittsburgh, Pennsylvania
- I'm interested
University of Pennsylvania
Philadelphia, Pennsylvania
- I'm interested
Thomas Jefferson University
Philadelphia, Pennsylvania
- I'm interested
Medical University of South Carolina
Charleston, South Carolina
- I'm interested
Vanderbilt University
Nashville, Tennessee
- I'm interested
Baylor College of Medicine
Houston, Texas
- I'm interested
The University of Texas Health Science Center at Houston
Houston, Texas
- I'm interested
University of Texas at San Antonio
San Antonio, Texas
- I'm interested
Intermountain Health
Murray, Utah
- I'm interested
Virginia Commonwealth University
Richmond, Virginia
- I'm interested
Evergreen Health
Kirkland, Washington
- I'm interested
Inland Northwest Research
Spokane, Washington
- I'm interested
Medical College of Wisconsin
Milwaukee, Wisconsin
Who can participate
Inclusion criteria
- ✓Study Population 1: PWP (open for recruitment)
- ✓1. Meet Movement Disorder Society (MDS) Clinical Diagnostic Criteria for Parkinson's Disease: probable diagnosis.
- ✓2. Willingness to undergo genetic testing, and choose to be informed of genetic testing results for GBA, LRRK2 and 5 additional PD related genes (SNCA, VPS35, PRKN, PINK-1, PARK7).
- ✓3. Capacity to give full informed consent in writing or electronically, and have read and signed the informed consent forms (ICFs) based on site clinician's determination.
- ✓4. Able to perform study activities (including completion of either online, in-person or paper surveys).
- ✓Study Population 2: People at risk of developing PD (not open for recruitment)
- ✓1\. Family members of Study Population 1 may be invited to participate in the study if confirmatory genetic testing is deemed necessary by the genetic testing laboratory.
Exclusion criteria
- ✕1. Diagnosis of an atypical parkinsonian disorder (i.e., multiple system atrophy, progressive supranuclear palsy, dementia with Lewy bodies, corticobasal syndrome), including that due to medications, metabolic disorders, encephalitis, cerebrovascular disease, or normal pressure hydrocephalus.
- ✕2. Individuals who have received a blood transfusion within the past 3 months.
- ✕3. Individuals who have active hematologic malignancies such as lymphoma or leukemia.
- ✕4. Individuals who have had a bone marrow transplant within the past 5 years.
- ✕5. Under the age of 18
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.